Cart
sales@molnova.com
Recainam
CAS No. 74738-24-2
Recainam( —— )
Catalog No. M36114 CAS No. 74738-24-2
Recainam is a novel, orally available compound with potent class I antiarrhythmic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 116 | Get Quote |
|
| 5MG | 168 | Get Quote |
|
| 10MG | 247 | Get Quote |
|
| 25MG | 466 | Get Quote |
|
| 50MG | 635 | Get Quote |
|
| 100MG | 884 | Get Quote |
|
| 500MG | 1773 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRecainam
-
NoteResearch use only, not for human use.
-
Brief DescriptionRecainam is a novel, orally available compound with potent class I antiarrhythmic activity.
-
DescriptionRecainam is a novel, orally available compound with potent class I antiarrhythmic activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number74738-24-2
-
Formula Weight263.38
-
Molecular FormulaC15H25N3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C(NCCCNC(C)C)=O)C1=C(C)C=CC=C1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Rilematovir
JNJ-678 is a novel inhibitor of the fusion protein. JNJ-678 shows the potential for respiratory syncytial virus (RSV) treatment.
-
Poricoic acid B
Poricoic acid B shows inhibitory activity against TPA-induced ear inflammatory oedema.
-
DX3-213B
DX3-213B is a potent, orally active inhibitor of oxidative phosphorylation (OXPHOS) complex I with an IC50 of 3.6 nM.
